The board of directors of MDxHealth SA appointed Mr. Donnie (Don) M. Hardison as an independent non-executive director. Mr. Hardison was most recently the President and Chief Executive Officer, and served on the board of directors, of Biotheranostics Inc., a molecular diagnostic company focused on oncology, from February 2017 until it was acquired by Hologic Inc. in February 2021. From April 2010 to March 2016, Mr. Hardison was the President and Chief Executive Officer of Good Start Genetics, a molecular genetic testing and information company. For more than 20 years prior to that, Mr. Hardison held various executive and senior management positions at companies including Laboratory Corporation of America (LabCorp), Exact Sciences Corporation, Quest Diagnostics Inc., and Smith Kline Beecham Corporation. He currently serves as an independent director on the boards of directors of Stemina Biomarker Discovery Inc., Seventh Sense Biosystems, BioPorto Inc. and IQuity Inc. He also formerly served on the board of directors of Exact Sciences Corporation from May 2000, through its initial public offering in February 2001, until August 2007. Mr. Hardison will continue the mandate of Mr. Timothy Still, who previously stepped down from the board of directors. His appointment as director will be submitted for confirmation to the next general shareholders' meeting of the Company.